Summary The production of the cytokines IFN-gamma, IL-1-alpha, IL-2 and TNF-alpha was investigated in mitogen-stimulated, whole blood cell culturs from 239 untreated patients with primary gynaecological carcinomas (breast, cervix, ovary, endometrium), and 191 healthy female controls.
The host's response to malignant tumours is usually considered to be primarily a function of the cellular immune system and various tests have been established to measure the integrity of this system in cancer patients, such as hypersensitivity skin tests (Bolton et al., 1975; Evans et al., 1977) , or determination of mitogen-induced lymphocyte proliferation in vitro (Dean et al., 1977; Zembala et al., 1977; Fritze & Dystant, 1984) .
As the cell-mediated immune response is controlled by a series of soluble cytokines, in recent years the measurement of these substances has also been used to determine the cellular immunological potency of tumour patients (Rey et al., 1983; Santos et al., 1985; Elsasser-Beile et al., 1991a) .
The current report focuses on measurements of several cytokines, produced by peripheral lymphocytes and monocytes upon initial triggering with a mitogenic stimulation and their evaluation as parameters for the actual immunity potential of tumour patients and controls.
The aim was to apply an easy-to-handle and reproducible whole blood cell culture system to a large patient group, investigating whether cellular immunity is depressed in these tumour patients and if there is a correlation between cytokine levels and growing tumour mass. Blood samples Ten ml of heparinised blood was taken from each patient and control person between 9 and 11 a.m. The samples, kept at room temperature, were used within 2 h. A 0.5 ml aliquot was removed for total and differential leukocyte counts.
Materials and methods

Patients
Whole blood cell culture (WBCC) Cultures were performed as previously described with a system for which optimal conditions and kinetics of cytokine production were established (Elsasser-Beile et al., 1991b) .
In brief, heparinised venous blood was diluted 1/10 with RPMI 1640 (Seromed, Berlin FRG), which was supplemented with 50 U ml-' Penicillin (Seromed) and 50 Sg ml-' Streptomycin (Seromed) and distributed in 0.5 ml aliquots in 12 mm polystyrol tubes. For stimulation, 10 ig ml-' phytohaemagglutinin (PHA Wellcome, Burgwedel, FRG) and 0.5-5 g.g ml-' Pokeweed mitogen (PWM, Sigma, Deisenhofen, FRG) were added.
Incubation of the cell cultures was performed at 37°C in a humidified atmosphere of 5% CO2. After 4 days of culture without changes of medium 320 ftl of supernatant was removed from each tube to be assayed for cytokine levels.
Determination of cytokines Enzyme-linked immunoassays (ELISA) were applied for qualitative and quantitative determinations of cytokines.
These tests are based on the sandwich principle and are performed in one step. Since a correlation was found between assay performance of the naturally occurring cytokines and their recombinant counterparts, the latter were used as standards.
Interferon-gamma-ELISA IFN-gamma levels in the supernatants were determined as previously described (Gallati et al., 1987 IFN-gamma values ranged between 10 and 375 ng ml-l with median values of 77 ng ml upon stimulation with 10 iLg ml1' PHA and 108 ng IFN-gamma ml-' ml upon stimulation with 5ygml'l PWM.
IL-2 levels were between 0 and 14,955pgml-' (median 1,055 pg ml-l for PHA-stimulation and 1,525 pg mll for PWM-stimulation).
The levels of the monokines were between 10 and 1,100 pg ml1' for IL-1-alpha and between 0 and 4,093pgml-' for TNF-alpha (Table I) .
Cytokine values in the WBCC ofpatients with breast cancer In the whole blood cell cultures of the 87 patients with breast cancer significantly lower values of IFN-gamma (P .0.001), IL-1-alpha (P. 0.01) and IL-2 (P. 0.001) were measured compared to the controls (Table 1) .
Considering different tumour stages we found that a decreased IFN-gamma production correlated with tumour burden: cells of the 53 patients with lymph node and/or distant organ metastases (N + M + ) produced values lower than those of 34 patients with only a small localised tumour (T1/T2, NO, MO). The differences were significant (P .0.05) and the distribution of the values is shown in Figure 1 .
There also were lower IL-l-alpha and IL-2 values in the cultures of the patients with metastasising tumours, however, the differences between the groups were not statistically significant. However, grouping these patients according to FIGO stage I to IV, we could show a positive correlation between tumour stage and depression of the cytokine production in the cultures after stimulation with both mitogens.
Differences between the groups and the controls were significant for IFN-gamma (P < 0.02) but not for IL-l-alpha and IL-2 (Figure 2 Cytokine production in the WBCC of the patients with endometrial carcinomas In the whole blood cell cultures of this group of carcinoma patients, significantly lower levels of IFN-gamma (P 0.001), IL-I-alpha (P < 0.01) and IL-2 (P < 0.01) were also measured than in those of the controls. As shown in Figure 4 , significantly lower IFN-gamma levels were found in the WBCC supernatants of those 20 patients with stage III/IV carcinomas than in the cultures of the 23 patients with stage I/II carcinomas (P < 0.05). For IL-1-alpha and IL-2 the same tendency (but no statistical significance) was found.
Leukocyte levels in carcinoma patients and controls In order to determine whether the observed impairment of cytokine production was due to a depletion of lymphocytes or monocytes, total and differential leukocyte counts were made from all blood samples. Total leukocyte, lympocyte and monocyte counts showed neither statistical differences between the tumour patients and the control subjects nor between different clinical stages of the tumour patients. :::: ...
Discussion
In the present study we were able to demonstrate that the mitogen-induced production of IFN-gamma, IL-1-alpha and IL-2 was significantly decreased in blood cell cultures from patients with gynaecological carcinomas as compared to normal female controls. We also found that this was not due to reduced leukocyte numbers in the blood samples. However, a rather wide range of the cytokine values was observed not only in the healthy control persons but also in the tumour patients, which probably corresponds to a broad physiological variation.
We found a decrease of the IFN-gamma levels with increasing clinical stage or tumour burden in all four tumour groups. This is in accordance with other papers dealing with the immune reactivity in patients with gynaecological carcinomas. Both decreased lymphocyte proliferation (Wanebo et al., 1978; Fritze & Dystant, 1984) and an impairment of delayed type hypersensitivity (Stein et al., 1976) was found in patients with breast cancer. Measurements of cytokine production in cell cultures have also been used to determine the immunological activity of breast cancer patients, but here the results were controversial. In one study, an impaired production of TNF was found (Zielinski et al., 1990 ) and a defective expression and release of the IL-2 receptors (Hakim, 1988) , while in another study the production of IL-2 was not diminished (Wanebo et al., 1986) . In lymphocyte cultures of patients with endometrial carcinomas a reduced IL-2 production has been described (Yron et al., 1986) .
The whole blood cell culture combined with enzymoimmunological tests, as used in this study, in an easy to handle and reproducible system which needs only small amounts of blood and allows the quick testing of large numbers of blood samples. Compared to cultures with isolated mononuclear cells it may better reflect the in vivo situation because cell populations are not altered and cells are not affected by the isolation procedures. Additional cell counting in each blood sample allows comparison of the results in the different tumour groups and controls. This could be supplemented with a T-cell subset phenyotyping. However, when comparing subsets in samples of other patients with solid carcinomas and controls no significant differences were seen (ElsasserBeile et al., 1992; 1993) , so we doubt if phenotyping would give much more information.
As already shown in another study (Elsasser-Beile et al., 1992) , of the tested cytokines IFN-gamma seems to be the best parameter for evaluating the cellular immunological competence of a patient because it is produced only by T-cells and NK-cells in high amounts upon T-cell activation and does not bind to its receptor as does IL-2. Since the whole blood system contains only less than 10% monocytes, the monokine secretion is relatively low and concentration differences are more difficult to demonstrate. This might explain that significant differences between patient groups with different tumour stages were seen with IFN-gamma only. From kinetic experiments, an incubation time of four days was chosen which is optimal for IFN-gamma and IL-1-alpha and acceptable for IL-2. For TNF-alpha, shorter incubation times might be better.
To our knowledge the present study is the first to provide information on the production of cytokines by peripheral lymphocytes from a rather 'large group of patients with various gynaecological carcinomas of different clinical stages, where a decreased cytokine production closely associated with the advancement of the tumour stage could be shown in all groups of carcinomas.
A broad variation was seen in patients with breast cancer and cervical carcinomas, where those patients with small localised tumours had only slightly lower lymphokine values than the controls, whereas those with metastasising tumours had much lower values. The situation was different in patients with ovarian and endometrial carcinomas. These carcinomas are mostly diagnosed in an advanced stage and also primary tumours comprise larger volumes.
From our results, we suggest that malignant disease gradually leads to a depression of the cellular immunity potential in the host as reflected by a lower cytokine production of his/her immunocompetent cells. A possible explanation for this impaired function of the lymphocytes and monocytes could be the presence of circulating immunosuppressive factors or an induction of suppressor cell populations as already postulated by other authors (Zembala et al., 1977; Bjercke et al., 1986) .
Our studies may help to clarify the state of the tumourhost relationship and they might be suitable for finding out those patients who are the most immunosuppressed and therefore may have a poor prognosis.
It will be interesting to determine whether the restoration of a decreased cytokine production would be indicative for a clinical amelioration and thus to verify, whether our system will provide a means to give an indication of the course of the cancerous disease.
